Biosimilar Medicines Conference

Let’s Shape What’s Next:
Join us for the 2026 Biosimilar Medicines Conference!

At a pivotal moment when global trade tensions and strategic policy shifts – such as the conclusion of the revision of the EU pharmaceutical Legislation, or the Critical Medicines Act and Biotech Act – are reshaping the healthcare and pharmaceutical landscape, biosimilar medicines stand at the crossroads of access, sustainability, and industrial resilience.

This year’s Biosimilar Medicines Conference programme will explore how strategic coalitions for change can emerge across value chains, geographies, and stakeholders to unlock the full potential of biosimilar medicines to deliver meaningful impact for patients, health systems and society at large.

Together, we will address essential questions surrounding market competition, access strategies, regulatory evolution, competitiveness, health outcome improvements for Non-Communicable Diseases – all within the context of a rapidly evolving global ecosystem and emerging industrial policy frameworks.

Your expertise and insights are invaluable to these critical conversations. Save the dates and join us in May 2026 as we collectively shape the future of biosimilar medicines within health and industrial policy!